SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Establishment Labs Holdings Inc. - ESTA
Pomerantz LLP is investigating claims on behalf of investors of Establishment Labs Holdings Inc. ("Establishment Labs" or the "Company") (NASDAQ: ESTA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980
NEW YORK, Nov. 14, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Establishment Labs Holdings Inc. ("Establishment Labs" or the "Company") (NASDAQ: ESTA). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980.
The investigation concerns whether Establishment Labs and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
On October 19, 2022, Hindenburg Research ("Hindenburg") published a report entitled "Establishment Labs: A Financially Stretched Silicone Safety Charade". The Hindenburg report asserted, among other allegations, that: "[t]he advisor Establishment just hired to support its U.S. launch was sued by the SEC in 2018 for fraudulently lying and then destroying records that concealed regulatory and safety issues with breast implants:; "[d]espite claims of superior safety, we found that almost all key safety studies touted by the company have conflicts of interest, with many undisclosed or under-disclosed"; and "Australian and French authorities expressed concerns with the company's data, with Australian regulators calling the company's main safety data 'observational uncontrolled studies'".
